| Dr Jonathan G Phillips, MD | |
|
924 Montclair Rd, Ste 200, Birmingham, AL 35213-1200 | |
| (205) 591-7999 | |
| (205) 591-5051 |
| Full Name | Dr Jonathan G Phillips |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 924 Montclair Rd, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013913730 | NPI | - | NPPES |
| AL000007469 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 15980 (Alabama) | Primary |
| Entity Name | Cytopath, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598759433 PECOS PAC ID: 4688656937 Enrollment ID: O20040602000583 |
News Archive
Today's headlines include reports that a federal judge on Wednesday rejected a legal challenge related to the health law's insurance subsidies.
Patients affected by a bacterial infection can usually be treated with an antibiotic. But sometimes a resistant bacterial strain is causing the infection. In a hospital setting, doctors ideally want to know if they are dealing with such bacteria and which drugs they should choose. But if the doctor runs a test it can take days to get a result. Now, a European project is paving the way for much more rapid tests using DNA biochips. The aim is to rapidly screen disease-causing bacteria using a microarray to spot which resistant genes are present in bacteria.
"On World No Tobacco Day (31 May), WHO is calling on national leaders to be extra vigilant against the increasingly aggressive attacks by the industry which undermine policies that protect people from the harms of tobacco," a WHO press release reports, noting that nearly six million people die of tobacco-related illnesses each year and tobacco is a leading preventable cause of illness and death worldwide.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.
In short, if the changes that are proposed for employer subsidies in the current Medicare Part D program are enacted, everyone will lose (Tom Scully, 12/3).
› Verified 2 days ago
| Entity Name | Urology Centers Of Alabama Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710962550 PECOS PAC ID: 0941264345 Enrollment ID: O20041116000389 |
News Archive
Today's headlines include reports that a federal judge on Wednesday rejected a legal challenge related to the health law's insurance subsidies.
Patients affected by a bacterial infection can usually be treated with an antibiotic. But sometimes a resistant bacterial strain is causing the infection. In a hospital setting, doctors ideally want to know if they are dealing with such bacteria and which drugs they should choose. But if the doctor runs a test it can take days to get a result. Now, a European project is paving the way for much more rapid tests using DNA biochips. The aim is to rapidly screen disease-causing bacteria using a microarray to spot which resistant genes are present in bacteria.
"On World No Tobacco Day (31 May), WHO is calling on national leaders to be extra vigilant against the increasingly aggressive attacks by the industry which undermine policies that protect people from the harms of tobacco," a WHO press release reports, noting that nearly six million people die of tobacco-related illnesses each year and tobacco is a leading preventable cause of illness and death worldwide.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.
In short, if the changes that are proposed for employer subsidies in the current Medicare Part D program are enacted, everyone will lose (Tom Scully, 12/3).
› Verified 2 days ago
| Entity Name | Cunningham Pathology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831195437 PECOS PAC ID: 2668468802 Enrollment ID: O20080218000071 |
News Archive
Today's headlines include reports that a federal judge on Wednesday rejected a legal challenge related to the health law's insurance subsidies.
Patients affected by a bacterial infection can usually be treated with an antibiotic. But sometimes a resistant bacterial strain is causing the infection. In a hospital setting, doctors ideally want to know if they are dealing with such bacteria and which drugs they should choose. But if the doctor runs a test it can take days to get a result. Now, a European project is paving the way for much more rapid tests using DNA biochips. The aim is to rapidly screen disease-causing bacteria using a microarray to spot which resistant genes are present in bacteria.
"On World No Tobacco Day (31 May), WHO is calling on national leaders to be extra vigilant against the increasingly aggressive attacks by the industry which undermine policies that protect people from the harms of tobacco," a WHO press release reports, noting that nearly six million people die of tobacco-related illnesses each year and tobacco is a leading preventable cause of illness and death worldwide.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.
In short, if the changes that are proposed for employer subsidies in the current Medicare Part D program are enacted, everyone will lose (Tom Scully, 12/3).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan G Phillips, MD 924 Montclair Rd, Ste 200, Birmingham, AL 35213-1200 Ph: (205) 591-7999 | Dr Jonathan G Phillips, MD 924 Montclair Rd, Ste 200, Birmingham, AL 35213-1200 Ph: (205) 591-7999 |
News Archive
Today's headlines include reports that a federal judge on Wednesday rejected a legal challenge related to the health law's insurance subsidies.
Patients affected by a bacterial infection can usually be treated with an antibiotic. But sometimes a resistant bacterial strain is causing the infection. In a hospital setting, doctors ideally want to know if they are dealing with such bacteria and which drugs they should choose. But if the doctor runs a test it can take days to get a result. Now, a European project is paving the way for much more rapid tests using DNA biochips. The aim is to rapidly screen disease-causing bacteria using a microarray to spot which resistant genes are present in bacteria.
"On World No Tobacco Day (31 May), WHO is calling on national leaders to be extra vigilant against the increasingly aggressive attacks by the industry which undermine policies that protect people from the harms of tobacco," a WHO press release reports, noting that nearly six million people die of tobacco-related illnesses each year and tobacco is a leading preventable cause of illness and death worldwide.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.
In short, if the changes that are proposed for employer subsidies in the current Medicare Part D program are enacted, everyone will lose (Tom Scully, 12/3).
› Verified 2 days ago
Dr. Kyle Charles Mills, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2800 Fax: 205-949-2801 | |
Leona Council, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5038 | |
Dr. Alexander Wong, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2806 Fax: 205-949-2875 | |
Dr. David Ullman, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-934-4977 | |
Thomas S Winokur, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Isam Eltoum, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 |